Illumina hit with record $476 million fine for closing Grail deal without EU approval

The European Commission last year blocked Illumina's $7.1 billion acquisition of Grail over concerns it would stifle innovation and consumer choice.

from Health and Science https://ift.tt/RqWPs10
https://ift.tt/nVD8NTL
https://ift.tt/RGmvEbz